Lapatinib in Combination With Capecitabine Versus Continued Use of Trastuzumab in Breast Cancer Patients With Trastuzumab-Resistance: A Retrospective Study of a Chinese Population
BMC Cancer - United Kingdom
doi 10.1186/s12885-020-6639-4
Full Text
Open PDFAbstract
Available in full text
Date
March 29, 2020
Authors
Publisher
Springer Science and Business Media LLC